Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nigel Lange Insider Profile
4 Followers
Nigel Lange, Chief Executive Officer & Managing Director at OncoSil Medical Ltd, holds 1.50M shares in OncoSil Medical Ltd (Ticker: AU:OSL). Most recently, Nigel Lange Bought AU$1,000,000 shares of OncoSil Medical Ltd on May 11, 2023 for an estimated value of 10.00K.
Nigel Lange has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Executive Officer & Managing Director
Roles that Nigel Lange holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Nigel Lange
Nigel Lange's Trading History
List of latest transactions for each holding click on a transaction to see Nigel Lange's performance on stock
You May Also Like
Nigel Lange insider profile FAQ
What is the percentage of profitable transactions made by Nigel Lange?
The percentage of profitable transactions made by Nigel Lange is ―.
What is the average return per transaction made by Nigel Lange?
The average return per transaction made by Nigel Lange is ―.
What stocks does Nigel Lange hold?
Nigel Lange holds: AU:OSL stocks.
What was Nigel Lange’s latest transaction?
Nigel Lange latest transaction was an Informative Buy of AU$10.00K.
What was Nigel Lange's most profitable transaction?
Nigel Lange’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Nigel Lange's role in OncoSil Medical Ltd?
Nigel Lange's role in OncoSil Medical Ltd is Chief Executive Officer & Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.